Elana Gotkine on Muck Rack

Elana Gotkine

Israel
As seen in: American Journal of Epidemiology, Infobae, Phys.org, Science Magazine, Medical Xpress, St. Louis Post-Dispatch, Wisconsin State Journal, Drugs.com, Arizona Daily Star, Newsmax and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Elana

Contact Elana, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Odds of HPV-Related Cancers Up for People With HIV, Solid Organ Transplant Recipients

|
By Elana Gotkine, Farrokh Sohrabi
| HealthDay Verified
FRIDAY, July 10, 2026 (HealthDay News) -- The odds of human papillomavirus (HPV)-related cancers are increased among people with HIV (PWH) and solid organ transplant recipients (SOTRs), according to a study published online June 30 in JAMA Network Open. Eva Meglic, from the Karolinska Institutet in Stockholm, and colleagues compared the odds of HPV-related cancers in PWH and SOTRs with control participants in a nested case-control study.
Open in Who Shared View Duplicates (2) Issue with article?

Customize your cookie preferences

|
By Elana Gotkine
| HealthDay Verified
FRIDAY July 10, 2026 (HealthDay News) -- About 31 percent of pediatric surgery patients receive an opioid prescription at discharge, according to a study published online June 23 in the Journal of the American College of Surgeons.
Open in Who Shared View Duplicates (2) Issue with article?

Customize your cookie preferences

|
By Elana Gotkine, Farrokh Sohrabi
| HealthDay Verified
FRIDAY, July 10, 2026 (HealthDay News) -- For patients with peripheral artery disease (PAD) and type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with lower rates of mortality, hospitalization, revascularization, and amputation, according to a study published online July 1 in the Journal of the American Heart Association.
Open in Who Shared Issue with article?
See all 147,168 licensed articles (156,077 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified